Literature DB >> 16181540

[Clinical observation of Gingko biloba extract injection in treating early diabetic nephropathy].

Jie Lu1, Hai He.   

Abstract

OBJECTIVE: To observe the effect of Ginkgo biloba extract injection (GB) in treating early diabetic nephropathy (DN).
METHODS: Sixty DN patients were divided into two groups, the treated group were treated by GB and Western medicine, and the control group were given Western medicine alone. The study lasted for 4 weeks. Fasting plasma glucose (FPG), blood pressure, 24 h urinary albumin excretion (UAE), endogenous creatinine clearance rate (Ccr), blood lipids and hemorheology indices were examined before and after the study.
RESULTS: Compared with the control group, UAE were significantly decreased (P < 0.01); Ccr, blood lipids and hemorheology indices were all improved after treatment in the treated group (P < 0.05 or P < 0.01). But in FPG and blood pressure there was no significant change between the treated group and the control group (P > 0.05).
CONCLUSION: GB is effective in treating early DN through decreasing urinary albumin excretion rate, regulating blood lipids, improving renal function and hemorheology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181540     DOI: 10.1007/bf02836510

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  3 in total

1.  Ginkgo Biloba Extract EGB761 Ameliorates the Extracellular Matrix Accumulation and Mesenchymal Transformation of Renal Tubules in Diabetic Kidney Disease by Inhibiting Endoplasmic Reticulum Stress.

Authors:  Jiarui Han; Xinxin Pang; Xiujie Shi; Yage Zhang; Zining Peng; Yufeng Xing
Journal:  Biomed Res Int       Date:  2021-03-23       Impact factor: 3.411

2.  The effect of chinese herbal medicine on albuminuria levels in patients with diabetic nephropathy: a systematic review and meta-analysis.

Authors:  Ya Xiao; Yanyan Liu; Keqiang Yu; Lin Zhou; Jianlu Bi; Jingru Cheng; Fei Li; Ren Luo; Xiaoshan Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-26       Impact factor: 2.629

Review 3.  Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective.

Authors:  Min Kyong Song; Neal M Davies; Basil D Roufogalis; Tom Hsun-Wei Huang
Journal:  J Diabetes Res       Date:  2014-04-13       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.